September 8th, 2021 Recommended Pre-Deployment Protocol eyed to lessen Crew Change Disruption

Daily COVID-19 infections in the Philippines have hit an all-time high driven by the more transmissible delta variant which is now the dominant strain in the country. Experts are expecting the numbers to remain high at least in the coming weeks.

September 8th, 2021 Gov’t implements online health pass platform for travelers arriving in PH

The Philippines opens it’s ‘One Health Pass’ portal which is an online registration for travelers and returning Filipinos.

September 8th, 2021 Vaccination for Filipino Seafarers continues but supply issues still a Problem

Both national and local governments in the Philippines are making strides to inoculate more seafarers. However, limited supply continues to be an issue in the rollout of COVID-19 vaccines in the country.

August 6th, 2021 Crossworld Operations Continue as Metro Manila Goes on Lockdown

Crossworld Marine Services, Inc. remains operational while Metro Manila undergoes a strict lockdown from August 06-20, 2021 amid the threat of the more transmissible COVID-19 Delta variant. 

August 6th, 2021 COVID-19 Vaccine Supply Still a Challenge in Ph

Crossworld Marine Services, Inc. congratulates the Duterte government for administering 18 million COVID-19 vaccines to Filipinos as of July 2022.

August 6th, 2021 COVID-19 Vaccination Requirement Guide for Foreign Countries

In an effort to bring more clarity on the crew vaccination requirements in various parts of the world, Crossworld has gathered a list of the vaccine brands being required by countries for foreigners entering their country.

July 2nd, 2021 Ph Seafarer Deployment Figures Rebound

The Philippines deployment for seafarers is starting to go back to pre–pandemic numbers according to the Philippine Overseas Employment Administration (POEA).

July 2nd, 2021 Ph allots Moderna COVID-19 Vaccines for Filipino Seafarers and Overseas Workers

Filipino seafarers and Overseas Filipino Workers will get COVID-19 Vaccine from U.S. drug manufacturer Moderna.